V
VolitionRx Limited (VNRX)
ASE – Real Time Price. Currency in USD
1.28
-0.01 (-0.78%)
At close: Jun 26, 2026, 4:00 PM EDT
1.28
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
1.28
-0.01 (-0.78%)
At close: Jun 26, 2026, 4:00 PM EDT
1.28
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:57 PM EDT
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
| Name | Position |
|---|---|
| Dr. Gaetan Michel Ph.D. | Chief Operating Officer |
| Dr. Jacob Vincent Micallef MBA, Ph.D. | Chief Scientific Officer |
| Dr. Jasmine Kway Ph.D. | Chief Executive Officer of Singapore Volition |
| Mr. Cameron Reynolds MBA | Founder, CEO, President & Director |
| Mr. Gael Forterre M.B.A. | Chief Commercial Officer |
| Mr. Nicholas Plummer | Group General Counsel |
| Mr. Rodney Gerard Rootsaert LLB | Corporate Secretary |
| Mr. Terig Hughes | CFO & Treasurer |
| Ms. Louise Batchelor Day | Group Chief Marketing & Communications Officer |
| Ms. Sharon Ballesteros | U.S. Head of Quality & Development Process |
| Date | Type | Document |
|---|---|---|
| 2026-06-18 | 8-K | vnrx_8k.htm |
| 2026-06-10 | 8-K | vnrx_8k.htm |
| 2026-06-02 | DEF 14A | vnrx_def14a.htm |
| 2026-05-22 | 8-K | vnrx_8k.htm |
| 2026-05-15 | 8-K | vnrx_8k.htm |
| 2026-05-14 | 10-Q | vnrx_10q.htm |
| 2026-05-13 | PRE 14A | vnrx_pre14a.htm |
| 2026-04-30 | 10-K/A | vnrx_10k.htm |
| 2026-04-28 | 8-K | vnrx_8k.htm |
| 2026-04-23 | 8-K | vnrx_8k.htm |